Stress has long been recognized as a pivotal factor influencing health behaviors, with substantial evidence indicating its role in exacerbating tendencies toward alcohol and tobacco use. The COVID-19 pandemic has not only elevated baseline stress levels globally but has also introduced unique psychosocial stressors, including social isolation, economic uncertainty, and health anxieties. These unprecedented circumstances amplify the imperative to understand how stress contributes to harmful coping mechanisms, especially considering the differential effects across sex and infection status.

Cho and colleagues employed a robust methodological framework by analyzing data from a large, representative U.S. adult survey carried out during the pandemic. This approach allowed for a granular examination of stress levels and their correlation with heavy drinking and smoking habits, stratified by sex and whether individuals had contracted COVID-19. Stress was quantified through validated psychometric instruments, while substance use patterns were assessed via standardized self-report measures. Such comprehensive data collection adds rigor to the study’s conclusions.

The study reveals that elevated stress levels are significantly linked to increased odds of heavy drinking and smoking, reinforcing existing theories about stress-induced substance use. Intriguingly, the magnitude of this association varied markedly between men and women, underscoring the importance of sex-specific vulnerabilities and coping mechanisms. While stress correlated with heavy drinking in both sexes, the association was notably stronger in men, suggesting that male individuals may be more prone to escalate alcohol consumption as a maladaptive stress response.

Conversely, the relationship between stress and smoking demonstrated a contrasting pattern. Women exhibited a more pronounced link between high stress and smoking intensity, pointing to potential sex differences in nicotine’s role as an anxiolytic agent. This divergence between sexes is critical from a neurobiological perspective, suggesting that reward pathways and stress regulation circuits may respond differently to nicotine and alcohol depending on hormonal and psychosocial factors.

Moreover, the researchers unveiled compelling modifications in these behaviors contingent upon COVID-19 infection status. Individuals who had been infected displayed unique profiles in their stress-substance use relations. For example, infected men showed an intensified association between stress and heavy drinking relative to their non-infected counterparts, possibly reflecting heightened psychological distress following illness or quarantine experiences. Such findings implicate post-infection stress as a catalyst for exacerbated substance use, thereby compounding health risks in a vulnerable population.

Women with a history of COVID-19 infection, meanwhile, demonstrated increased stress-related smoking tendencies compared to uninfected women, suggesting that infection may amplify nicotine dependency or cravings under stress in this group. The biological aftermath of COVID-19, including systemic inflammation and neuropsychiatric sequelae, could mechanistically underlie these behavioral shifts. These data highlight the necessity for targeted interventions that consider the biological and psychosocial ramifications of COVID-19.

From a public health policy standpoint, this research underscores the need for differentiated approaches addressing substance use amid pandemic-induced stressors. Gender-sensitive interventions must be prioritized, recognizing that men and women might require tailored prevention and treatment strategies targeting alcohol and tobacco use, respectively. Furthermore, post-COVID care programs should integrate mental health support with substance use counseling to mitigate compounded risks.

The study’s reliance on cross-sectional data, while limiting causal inferences, nonetheless offers robust associative patterns that inform future longitudinal research. As ongoing waves of infection and evolving viral variants persist, continuous surveillance of substance use behaviors in relation to stress and infection status remains imperative. Understanding how acute and chronic stress responses to a global health crisis influence addiction pathways can guide preparedness for similar future events.

Importantly, this research contributes to a growing body of evidence emphasizing the biopsychosocial model of addiction. By integrating factors such as biological sex, infectious disease status, and psychological stress, the investigators present a multidimensional perspective that advances beyond one-size-fits-all paradigms. Such insights are invaluable for clinicians, epidemiologists, and policymakers seeking to curtail the intertwined epidemics of COVID-19 and substance misuse.

The findings also illuminate potential neuroendocrine mechanisms driving these sex-dependent behavioral variations. Hormones like estrogen and testosterone, known to modulate stress responses and addictive behaviors, may underlie the differential sensitivity to stress-induced alcohol and tobacco use. Investigating these pathways could lead to novel pharmacological interventions that are sex-specific and infection-sensitive.

Moreover, the social determinants of health cannot be overlooked when interpreting these results. Factors such as employment status, social support, and access to healthcare likely intersect with stress and substance use patterns, especially in the context of a pandemic. Future studies incorporating these variables can deepen the understanding of who is most at risk and why.

One particularly striking aspect of this research is its potential to inform digital health tools and telemedicine platforms designed to monitor and intervene in real time for stress-induced risky behaviors. As the pandemic has accelerated the adoption of remote health technologies, leveraging these findings can enhance personalized care that dynamically adjusts to an individual’s stress levels and COVID-19 history.

In conclusion, the study by Cho et al. offers a compelling, nuanced portrait of how stress intricately weaves into the fabric of heavy drinking and smoking behaviors amid the ongoing COVID-19 crisis. By highlighting the critical moderating roles of biological sex and infection status, this research charts a sophisticated roadmap for targeted interventions. As societies grapple with the dual legacies of the pandemic—the direct physiological impacts and the psychological aftermath—such evidence-based insights are crucial for fostering resilience and healthier coping mechanisms in vulnerable populations.

Subject of Research: The association between stress levels and heavy drinking and smoking behaviors, with a focus on sex differences and COVID-19 infection status among U.S. adults.

Article Title: Association of Stress Level with Heavy Drinking and Smoking Depending on Sex and COVID-19 Infection Status: A Cross-sectional Analysis of a Nationally Representative US Adult Survey.

Article References:
Cho, B., Pan, Y. & Stallings-Smith, S. Association of Stress Level with Heavy Drinking and Smoking Depending on Sex and COVID-19 Infection Status: A Cross-sectional Analysis of a Nationally Representative US Adult Survey. Int J Ment Health Addiction (2026). https://doi.org/10.1007/s11469-025-01627-7

Image Credits: AI Generated

DOI: https://doi.org/10.1007/s11469-025-01627-7

Panic disorder, a debilitating anxiety condition marked by sudden and recurrent panic attacks, has long been linked to increased risk of substance abuse. The Rutgers-led team, headed by Dr. Michele Pato, delved into how sex differences modulate these associations. Their findings underscore that men with panic disorder exhibit notably higher risk scores for problematic alcohol use compared to women with the same diagnosis, an observation that challenges conventional wisdom and encourages a re-evaluation of gender-tailored therapeutic strategies.

The methodological innovation of the study lies in leveraging “presumed” diagnostic criteria via screening instruments rather than formal clinical diagnoses. This approach enabled the inclusion of a significantly larger, demographically heterogeneous population, ensuring robust statistical power. Comprising 56% female participants and balanced ethnic representation—55% European ancestry and 45% African ancestry—the cohort offers a unique lens to disentangle genetic, biological, and sociocultural factors influencing comorbid conditions.

Contrary to some prior research suggesting ancestry-related variability in substance use comorbidities, the study found no significant differences in substance use disorder patterns between ancestral groups among those with panic disorder. This points toward a more universal biological or psychosocial underpinning of substance use disorders in the context of panic disorder, irrespective of ancestral genetic background.

One of the most compelling aspects of the research is the nuanced insight into the moderating role of sex in the nexus between panic disorder and alcohol misuse. While females generally experience higher rates of panic disorder, males with panic disorder seem disproportionately vulnerable to alcohol misuse. Dr. Pato hypothesizes that this may reflect self-medication tendencies unique to males, possibly influenced by underlying neurobiological and hormonal mechanisms, such as differential activation of stress-response circuits or sex steroid effects on addiction pathways.

Moreover, the study highlights the complex burden faced by individuals with co-occurring panic disorder and posttraumatic stress disorder (PTSD). Those with these dual anxiety diagnoses show substantially heightened risks for both alcohol and tobacco use disorders, elucidating how overlapping psychiatric conditions can amplify susceptibility to substance use. Understanding these layered vulnerabilities is pivotal for designing integrated treatment approaches that concurrently address multiple facets of mental health.

These findings carry significant clinical implications; specifically, they advocate for sex-specific screening protocols within psychiatric settings. Male patients presenting with panic symptoms might benefit from more rigorous assessment for alcohol misuse risks, while females might require differently tailored interventions. Dr. Michael Chung, lead author affiliated with New York University Langone Medical Center, emphasizes that incorporating biological sex into treatment planning can substantially enhance therapeutic outcomes and reduce relapse rates.

The research also prompts vital questions about the underlying neurobiological substrates contributing to these sex differences. Current hypotheses point toward sex-specific variations in neurotransmitter systems such as GABAergic and dopaminergic pathways, alongside hormonal influences like testosterone and estrogen, which may modulate response to both panic and alcohol use. Unpacking these mechanisms could pave the way for pharmacological innovations that precisely target these sex-dependent vulnerabilities.

Beyond biology, sociocultural elements warrant close examination. Traditional masculinity norms, societal stigmas around mental health, and differential help-seeking behaviors may all contribute to the higher rates of substance use disorders in males with panic. Men might be less inclined to access professional mental health services, turning instead to substance use as a maladaptive coping mechanism. Addressing these socio-psychological dimensions is crucial for a holistic understanding and crafting effective interventions.

The integration of expansive genomic data with psychiatric phenotyping, as exemplified by this study, signifies a paradigm shift in mental health research. By harnessing the power of large-scale cohorts and advanced statistical methodologies, scientists can now map complex gene-environment interactions that underpin mental disorders and their comorbidities. This trajectory holds immense promise for precision medicine approaches in psychiatry.

Overall, this study challenges the field to reconsider one-size-fits-all models of anxiety and addiction comorbidity. The demonstrated sex-dependent differentials in substance use risk highlight the necessity for personalized, gender-informed clinical frameworks that recognize the heterogeneity in mental health disorders. Such approaches are poised to improve diagnostics, tailor interventions, and ultimately alleviate the profound burdens of anxiety and addiction on millions worldwide.

As our understanding of these intertwined disorders evolves, so too must the strategies deployed by clinicians and researchers. Future investigations are encouraged to dissect the neuroendocrine and psychosocial drivers of sex disparities in panic disorder and substance use, potentially uncovering novel therapeutic targets. Meanwhile, public health initiatives might benefit from incorporating gender-sensitive messaging and outreach to better support affected populations.

This landmark research represents a critical contribution to psychiatric genetics and epidemiology, advancing the vision of integrative psychiatry that bridges molecular insights with clinical realities. The article titled "Sex differences in alcohol and tobacco use disorders among individuals with panic disorder: A cross-sectional analysis from the genomic psychiatry cohort" is accessible online via the journal Genomic Psychiatry, offering an invaluable resource for scholars, clinicians, and policy makers seeking to deepen their understanding of the multifaceted relationships between anxiety disorders and substance use.

Subject of Research: People

Article Title: Sex differences in alcohol and tobacco use disorders among individuals with panic disorder: A cross-sectional analysis from the genomic psychiatry cohort

News Publication Date: 22-Apr-2025

Web References: https://doi.org/10.61373/gp025a.0020

Image Credits: Michele Pato

Keywords: Panic disorder, alcohol use disorder, tobacco use disorder, sex differences, comorbidity, psychiatric genetics, anxiety disorders, substance use, neurobiology, psychiatric epidemiology, Genomic Psychiatry Cohort